Selenium in Cancer Prevention: Clinical Issues and Implications

REFERENCES

• Greenlee R. T., Hill-Harmon M. B., Murray T., Thun M. Cancer Statistics, 2001. CA Cancer J. Clin. 2001; 51: 15–36
   PubMed Web of Science ®Google Scholar
• Burner S. T., Waldo D. R., McKusick D. R. National Health Expenditures Projections Through 2030. Health Care Financ. Rev. 1992; 14: 1–15
   PubMedGoogle Scholar
• Schuette H. L., Tucker T. C., Brown M. L., Potosky A. L., Samuel T. The Costs of Cancer Care in the United States. Implications for Action. Oncology 1997; 9(11suppl)19–22
   Google Scholar
• Greenwald P., McDonald S. S. Cancer Prevention: The Roles of Diet and Chemoprevention. Cancer Control 1997; 4: 118–127
   PubMedGoogle Scholar
• Gaziano J. M., Hennekins C. H., Buring J. E. Methodological Issues in the Design of Primary Prevention Trials. IARC Sci. Publ. 1996; 136: 7–12
   PubMedGoogle Scholar
• Doll R. The Lessons of Life: Keynote Address to the Nutrition and CancerConference. Cancer Res. 1992; 52(suppl)2024S–2029S
   PubMedGoogle Scholar
• Medina D., Morrison D. G. Current Ideas on Selenium as a Chemopreventive Agent. Pathol. Immunopathol. Res. 1998; 7: 187–199
   Google Scholar
• El-Bayoumy K. The Role of Selenium in Cancer Prevention. Cancer Principles and Practices of Oncology, V. T. DeVita, S. Hellman, S. S. Rosenberg. 4th, Lippincott, Philidelphia 1991; 1–15
   Google Scholar
• Ip C. Lessons from Basic Research in Selenium and Cancer Prevention. J. Nutr. 1998; 128: 1845–1854
   PubMed Web of Science ®Google Scholar
• Combs G. F., Jr., Gray W. P. Chemopreventive Agents:Selenium. Pharmacol. Ther. 1998; 79: 179–192
   PubMed Web of Science ®Google Scholar
• Combs G. F., Jr., Clark L. C. Selenium and Cancer. Nutritional Oncology, G. B. Heber, V. L.W. Go. Academic, New York 1999; 215–222
   Google Scholar
• Clark L. C., Combs G. F., Jr., Turnbull B. W., Slate E. H., Chalker D. K., Chow J. D., Glover R. A., Graham G. F., Gross E. G., Krograd A., Lesher J. L., Park H. K., Smith C. L., Taylor J. R. Effects of Selenium Supplementation for Cancer Prevention inPatients with Carcinoma of the Skin A Randomized Controlled Trial. JAMA 1996; 276: 1957–1963
   PubMed Web of Science ®Google Scholar
• Yu S., Zhu Y., Li W. Protective Role of Selenium Against Hepatitis B Virus and PrimaryLiver Cancer in Qidong. Biol. Trace Elem. Res. 1997; 56: 117–124
   PubMed Web of Science ®Google Scholar
• Ganther H. E. Selenium Metabolism, Selenoproteins and Mechanisms of CancerPrevention: Complexities with Thioredoxin Reductase. Carcinogenesis 1999; 20: 1657–1666
   PubMed Web of Science ®Google Scholar
• Ganther N. Selenium Metabolism and Mechanisms of Cancer Prevention. Nutrition and Cancer Prevention:New Insights into the Role of Phytochemicals. Plenum/Kluwer, New York 2001, inpress
   Google Scholar
• Lü J. Apoptosis and Antiangiogenesis in Cancer Prevention by Selenium. Nutrition and Cancer Prevention: New Insights into the Role ofPhytochemicals. Plenum/Kluwer, New York 2001, inpress
   Google Scholar
• Fearon E. R., Vogelstein B. A Genetic Model for Colorectal Tumorigenesis. Cell 1986; 46: 3384–3388
   Google Scholar
• Hanahan D., Weinberg R. The Hallmarks of Cancer. Cell 2000; 100: 57–70, (review)
   PubMed Web of Science ®Google Scholar
• Sporn M. Carcinogenesis and Cancer: Different Perspectives on the SameDisease. Cancer Res. 1991; 51: 6215–6218
   PubMed Web of Science ®Google Scholar
• Greenwald P. Preventive Clinical Trials: An Overview. Ann. N.Y. Acad. Sci. 1995; 768: 129–140
   PubMed Web of Science ®Google Scholar
• Wattenberg L. W. Prevention-Therapy-Basic Science and the Resolution of the CancerProblem: Presidential Address. Cancer Res. 1993; 53: 5890–5896
   PubMed Web of Science ®Google Scholar
• Kelloff G. J., Boone C. W., Steele V. E. Progress in Cancer Chemoprevention: Perspectives in Agent Selectionand Short-Term Clinical Intervention Trials. Cancer Res. 1994; 54((suppl))2015–2024
   Google Scholar
• Kelloff G. J., Johnson J. R., Crowell J. A., Boone C. W., DeGeorge J. J., Steele V. E., Mehta M. U., Temech J. W., Schmidt W. J., Burke G., Greenwald P., Temple R. J. Guidance for Development of Chemopreventive Agents. J. Cell Biochem. 1994; 20(suppl)25–31
   Google Scholar
• Kelloff G. J., Crowell J. A., Boone C. A., Steele V. E., Lubet R. A., Greenwald P., Alberts D. S., Covey J. M., Doody L. A., Knapp G. G., Nayfield S., Parkinson D. R., Prasad V. K., Prorok P. C., Sausville E. A., Sigman C. C. Strategy and Planning for Chemoprevention Drug Development:Clinical Development Plans. J. Cell Biochem. 1994; 20(suppl)55–62
   Google Scholar
• Kelloff G. J., Hawk E. T., Crowell J. A., Steele V. E., Lubet R. A., Greenwald P., Alberts D. S., Covey J. M., Doody L. A., Knapp G. G., Nayfield S., Parkinson D. R., Prasad V. K., Prorok P. C., Sausville E. A., Sigman C. C. Strategies for Identification and Clinical Evaluation of PromisingChemopreventive Agents. Oncology 1996; 10: 1471–1487
   PubMedGoogle Scholar
• Perera F. P. Molecular Epidemiology: Insights into Cancer Susceptibility,Risk Assessment, and Prevention. J.Natl. Cancer. Inst. 1996; 88: 496–509
   PubMed Web of Science ®Google Scholar
• Kelloff G. J., Lieberman R., Steele V. E., Boone C. W., Lubet R. A., Kopelovitch L., Malone W. A. Chemoprevention of Prostate Cancer: Concepts and Strategies. Eur. Urol. 1999; 35: 342–350
   PubMed Web of Science ®Google Scholar
• Boone C. W., Kelloff G. J. Biomarker End-Points in Cancer Chemoprevention Trials. IARC Sci. Publ. 1997; 142: 273–280
   PubMedGoogle Scholar
• Sandler R. S. Aspirin and Other Nonsteroidal Anti-In-flammatory Agents in the Prevention of Colorectal Cancer. Important Advances in Oncology, V. T. DeVita, Jr., S. A. Rosenberg. Lippincott-Raven, Philadelphia 1995; 123–137
   Google Scholar
• Clark L. C., Alberts D. S. Selenium and Cancer: Risk or Protection. J. Natl. Cancer Inst. 1995; 87: 473–475, (editorial)
   PubMed Web of Science ®Google Scholar
• Combs G. F., Jr. Selenium. Nutrition and CancerPrevention, T. Moon, M. Micozzi. Marcel Dekker, New York 1989; 389–420
   Google Scholar
• Kritchevsky D. Caloric Restriction and Experimental Mammary Carcinogenesis. Breast Cancer Res. Treat. 1997; 46: 161–167
   PubMed Web of Science ®Google Scholar
• Weindruch R., Albanes D., Kritchevsky D. The Role of Calories and Caloric Restriction in Carcinogenesis. Hematol. Oncol. Clin. North Am. 1991; 5: 79–89
   PubMed Web of Science ®Google Scholar
• Yan L., Yee J. A., McGuire M. H., Graef G. L. Effect of Dietary Supplementation of Selenite on Pulmonary Metastasisof Melanoma Cells in Mice. Nutr. Cancer 1997; 28: 165–169
   PubMed Web of Science ®Google Scholar
• Yan L., Yee J. A., Li D., McGuire M. H., Graef G. L. Dietary Supplementation of Selenomethionine Reduces Metastasisof Melanoma Cells in Mice. Anticancer Res. 1999; 19: 1337–1342
   PubMed Web of Science ®Google Scholar
• Birt D. F., Julius A. D., Runice C. E., White L. T., Pour P. M. Enhancement of BOP-Induced Pancreatic Carcinogenesis in Selenium-FedSyrian Golden Hamsters Under SpecificDietary Conditions. Nutr. Cancer 1988; 11: 21–33
   PubMed Web of Science ®Google Scholar
• Appel M. J., Van Garderen-Hoetmer A., Woutersen R. A. Lack of Inhibitory Effect of Beta-Carotene, Vitamin C, VitaminE andSelenium on Development of Ductular Adenocarcinomas in Exocrine Pancreasof Hamsters. Cancer Lett. 1996; 103: 157–162
   PubMed Web of Science ®Google Scholar
• Combs G. F., Jr., Combs S. The Biological Availability of Selenium in Foods and Feeds. The Role of Selenium in Nutrition, G. F. Combs, Jr., S. Combs. Academic, New York 1986; 127–177
   Google Scholar
• Combs G. F., Jr., Combs S. Biological Function of Selenium-Dependent Glutathione Peroxidase. The Role of Selenium in Nutrition, G. F. Combs, Jr., S. Combs. Academic, New York 1986; 205–220
   Google Scholar
• Combs G. F., Jr., Combs S. Dietary Requirements of Selenium for Laboratory and Livestock Species. The Role of Selenium in Nutrition, G. F. Combs, Jr., S. Combs. Academic, New York 1986; 310–312
   Google Scholar
• National Research Council. Subcommittee on the Tenth Edition of the RDA's. NationalAcademy Press, Washington, DC 1989
   Google Scholar
• Stadtman T. C. Selenocysteine. Ann. Rev. Biochem. 1996; 65: 83–100
   PubMed Web of Science ®Google Scholar
• Berry M. J., Bannu L., Harney J. W., Larsen P. R. Functional Characterization of the Eukaryotic SECIS ElementsWhich Direct Selenocysteine Insertion at UGA Codons. EMBO J. 1993; 12: 3315–3322
   PubMed Web of Science ®Google Scholar
• Fox J. M., Poirier K. A., Watrach A. M. Selenium: Nutritional Implications and Prospects for TherapeuticMedicine. Methods Find. Exp. Clin. Pharmacol 1992; 14: 275–287
   PubMed Web of Science ®Google Scholar
• Yang G. Q., Ge K. Y., Chen J. S., Chen X. S. Selenium Related Endemic Diseases and the Daily Selenium Requirementof Humans. World Rev. Nutr. Diet 1988; 55: 98–152
   PubMedGoogle Scholar
• Moreno-Reyes R., Suetens C., Mathieu F., Begaux F., Zhu D., Rivera M. T., Boelaert M., Neve J., Perlmutter N., Vanderpas J. Kashin-Beck Osteoarthropathy in Rural Tibet in Relation to Seleniumand Iodine Status. N. Engl. J. Med. 1998; 339: 1112–1120
   PubMed Web of Science ®Google Scholar
• Vanderpas J. B., Contemper B., Duale N. L., Goessen W., Bebe N., Ntambue K., Dumont J., Thilly C. H., Diplock A. T. Iodine and Selenium Deficiency Associated with Creatinism inNorthern Zaire. Am. J. Clin. Nurtr. 1990; 52: 1087–1093
   PubMed Web of Science ®Google Scholar
• Robberecht H., Deelstra H. Factors Influencing Blood Selenium Concentration Values: A LiteratureReview. J. Trace Elem. Electrolytes Health Dis. 1994; 8: 129–143
   PubMed Web of Science ®Google Scholar
• Spallholz J. E. On the Nature of Selenium Toxicity and Carcinostatic Activity. Free Radical Biol. Med. 1994; 17: 45–64
   PubMed Web of Science ®Google Scholar
• Kiremidjian-Schumacher L., Stotzky G. Selenium and Immune Responses. Environ. Res. 1987; 42: 277–303
   PubMed Web of Science ®Google Scholar
• Kiremidjian-Schumacher L., Roy M., Wishe H. I., Cohen M. W., Stotzky G. Supplementation of Selenium and Human Immune Cell Functions.II. Effect on Cytotoxic Lymphocytes and Natural Killer Cells. Biol. Trace Elem. Res. 1994; 41: 115–126
   PubMed Web of Science ®Google Scholar
• Kiremidjian-Schumacher L., Roy M., Wishe H. I., Cohen M. W., Stotzky G. Supplementation of Selenium Augments the Functions of NaturalKiller and Lymphokine-Activated Killer Cells. Biol. Trace Elem. Res. 1996; 52: 227–239
   PubMed Web of Science ®Google Scholar
• Roy M., Kiremeidjian-Schumacher L., Wishe H. I. Supplementation with Selenium and Human Immune Cell FuctionsI. Effect of Lymphocyte Proliferation and Interleukin 2 Receptor Expression. Biol. Trace Elem. Res. 1994; 41: 103–113
   PubMed Web of Science ®Google Scholar
• Koller L. D., Exon J. H., Talcott P. A., Henningsen G. M. Immune Responses in Rats Supplemented with Selenium. Clin. Exp. Immunol 1986; 63: 570–576
   PubMed Web of Science ®Google Scholar
• Petrie H. T., Klassen L. W., Klassen P. S., O'Dell J. R., Kay H. D. Selenium and the Immune Response: II. Enhancement of MurineCytotoxic T-Lymphocyte and Natural Killer Cell Cytotoxicity In Vivo. J. Leukocyte Biol. 1989; 45: 215–220
   PubMed Web of Science ®Google Scholar
• Harr J. R., Exon J. H., Whanger P. D., Weswig P. H. Effect of Dietary Selenium on N-2-Fluorenyl Acetamide (FFA)-InducedCancer in Vitamin E-Supplemented, Selenium-Depleted Rats. Clin. Toxicol 197; 5: 187–194
   Google Scholar
• Besbris H. J., Wortzman M. S., Cohen A. M. Effect of Dietary Selenium on the Metabolism and Excretion of2-Acetylaminofluorene in the Rat. J. Toxicol. Environ. Health 1982; 9: 63–76
   PubMed Web of Science ®Google Scholar
• Fiala E. S., Joseph C., Sohn O. S., El-Bayoumy K., Reddy B. S. Mechanism of Benzylselenocyanate Inhibition of Azoxmethane-InducedColon Carcinogenesis in F344 Rats. Cancer Res. 1991; 54: 2826–2830
   Google Scholar
• Liu J. Z., Gilbert K., Parker H. M., Haschek W. M., Milner J. A. Inhibition of 7,12-Dimethylbenz(a)anthracene-Induced MammaryTumors and DNA Adducts by Dietary Selenite. Cancer Res. 1991; 51: 4613–4617
   PubMed Web of Science ®Google Scholar
• Liu J. Z., Zhang B. Z., Milner J. A. Dietary Selenite Modifies Glutathione Metabolism and 7,12Dimethylbenz(a)anthraceneConjugation in Rats. J. Nutr. 1994; 124: 172–180
   PubMed Web of Science ®Google Scholar
• Wilson A. C., Thompson H. J., Schedin P. J., Gibson N. W., Ganther H. E. Effect of Methylated Forms of Selenium on Cell Viability andthe Induction of DNA Strand Breakage. Biochem. Pharmacol 1992; 43: 1137–1141
   PubMed Web of Science ®Google Scholar
• Lü J., Kaeck M., Jiang C. Selenite Induction of DNA Strand Breaks and Apoptosis in MouseLeukemia L1210 Cells. Biochem. Pharmacol 1994; 47: 1531–1534
   PubMed Web of Science ®Google Scholar
• Thompson H. J., Wilson A., Lü J., Sigh M., Jiang C., Upadhyaya P., El-Bayoumy K., Ip C. Comparison of the Effects of an Organic and Inorganic Form ofSelenium on a Mammary Carcinoma Cell Line. Carcinogenesis 1994; 15: 183–186
   PubMed Web of Science ®Google Scholar
• Lü J., Jiang C., Kaeck M., Ganther H., Ip C., Thompson H. Cellular and Metabolic Effects of Triphenylselenonium Chloridein a Mammary Cell Culture Model. Carcinogen 1995; 16: 513–516
   PubMed Web of Science ®Google Scholar
• Lanfear J., Flemming J., Wu L., Webster G., Harrison P. R. The Selenium Metabolite Selenodiglutathione Induces p53 andApoptosis: Relevance to the Chemopreventive Efforts of Selenium. Carcinogenesis 1994; 15: 1387–1392
   PubMed Web of Science ®Google Scholar
• Zhu Z., Kimura M., Itokawa Y., Aoki T., Takahasi J. A., Nakatsu S., Oda Y., Kikuchi H. Apoptosis Induced by Selenium in Human Glioma Cell Lines. Biol. Trace Elem. Res. 1996; 54: 123–134
   PubMed Web of Science ®Google Scholar
• Stewart M. S., Davis R. L., Walsh L. P., Pence B. C. Induction of Differentiation and Apoptosis by Sodium Selenitein Human Colonic Carcinoma Cells (HT29). Cancer Lett. 1997; 11: 735–40
   Google Scholar
• Redman C., Xu M. J., Peng Y. M., Scott J. A., Payne C., Clark L., Nelson M. S. Involvement of Polyamines in Selenomethionine Induced Apoptosisand Mitotic Alterations in Human Tumor Cells. Carcinogen 1997; 18: 1195–1202
   PubMed Web of Science ®Google Scholar
• Lü J., Pei H., Ip C., Lisk D., Ganther H., Thompson H. J. Effects of an Aqueous Extract of High-Selenium Garlic on InVitro Markers and In Vitro Efficacy in Cancer Prevention. Carcinogenesis 1996; 17: 1903–1907
   PubMed Web of Science ®Google Scholar
• Lü J., Jiang C., Kaeck M., Ganther H., Vadhanavikit S., Ip C., Thompson H. J. Dissociation of the Genotoxic and Growth Inhibitory Effectsof Selenium. Biochem. Pharmacol 1995; 252: 7392–7394
   Google Scholar
• Jiang C., Jiang W., Ip C., Ganther H., Lü J. Selenium-Induced Inhibition of Angiogenesis in Mammary Cancerat Chemopreventive Levels of Intake. Mol. Carcinogenesis 1999; 26: 213–225
   PubMed Web of Science ®Google Scholar
• Lü J., Jiang C., Wang Z., Ganther H. Methylselenolas a Proximal Selenium Metabolite that Inhibits Vascular Matrix Metalloproteinasesand Angiogenesis. Presented atthe AACR Annual Meeting, San Francisco, CA, 2000
   Google Scholar
• Spyrou G., Bjornstedt M., Skog S., Holmgren A. Selenite and Selenate Inhibit Human Lymphocyte Growth via DifferentMechanisms. Cancer Res. 1996; 55: 4407–4412
   Google Scholar
• Bjornstedt M., Kumar S., Holmgren A. Selenodiglutathione Is a Highly Efficient Oxidant of ReducedThioredoxin and a Substrate for Mammalian Thioredoxin Reductase. J. Biol. Chem. 1992; 267: 8030–8034
   PubMed Web of Science ®Google Scholar
• Wu L., Lanfear J., Harrison P. R. The Selenium Metabolite Selenodiglutathione Induces Cell Deathby a Mechanism Distinct from H2O2Toxicity. Carcinogen 1995; 16: 1579–1584
   PubMed Web of Science ®Google Scholar
• Bjornstedt M., Kumar S., Bjorkhem L., Spyrou G., Holmgren A. Selenium and Thioredoxin and Glutaredoxin Systems. Biomed. Environ. Sci. 1997; 10: 271–279
   PubMedGoogle Scholar
• Vernie L. N., Hamburg C. J., Bont W. S. Inhibition of the Growth of Malignant Mouse Lymphoid Cells bySelenodiglutathione and Selenocystine. Cancer Lett. 1981; 14: 303–308
   Web of Science ®Google Scholar
• Vernie L. N. Inhibition of Protein Synthesis and Anticarcinogencity of Selenium Compounds. Proceedings of the Third International Symposium on Selenium inBiology Medicine, G. F. Combs, Jr., J. E. Spallholz, O. A. Lavender, J. E. Oldfield. AVI, Westport, CT 1987; 1074–1083
   Google Scholar
• Pence B. C., Stewart M., Walsh L., et al. Modulation of Oxidative Damage to DNA by Sodium Selenite via the Mechanism of Apoptosis. Proceedings of the 6th International Symposium on Selenium in Biologyand Medicine. Beijing, ILSI 1996; 82
   Google Scholar
• Poirer K. A., Milner J. A. Factors Influencing the Antitumorigenic Properties of Seleniumin Mice. J. Nutr. 1983; 113: 2147–2154
   PubMed Web of Science ®Google Scholar
• Harrison P. R., Lanfear J., Wu L., Fleming J., McGarry M., Blower L. Chemopreventive and Growth Inhibitory Effects of Selenium. Biomed. Environ. Sci. 1997; 10: 235–245
   PubMedGoogle Scholar
• Seko Y, Saito Y., Kitahara J., Imura N. Active Oxygen Generation by the Reaction of Selenite with Reduced Glutathione In Vitro. Proceedings of the Fourth International Symposium on Selenium inBiology and Medicine, A. Wendel. Springer-Verlag, Heidelberg 1989; 70–73
   Google Scholar
• Ip C., El-Bayoumy K., Upadhyaya P., Ganther H., Vadanavikit S., Thompson H. J. Comparative Effect on Inorganic and Organic Selenocyanate Derivativesin Mammary Cancer Prevention. Carcinogenesis 1994; 15: 187–192
   PubMed Web of Science ®Google Scholar
• Ip C., Ganther H. Activity of Methylated Forms of Selenium in Cancer Prevention. Cancer Res. 1990; 50: 1206–1211
   PubMed Web of Science ®Google Scholar
• Ip C., Ganther H. E. Comparison of Selenium and Sulfur Analogs in Cancer Prevention. Carcinogenesis 1992; 13: 1167–1170
   PubMed Web of Science ®Google Scholar
• Ip C., Ganther H. E. Biological Activities of Trimethylselenonium as Influenced byArsenite. J. Inorgan. Biochem. 1992; 46: 215–222
   PubMed Web of Science ®Google Scholar
• Ip C., Hayes C., Budnick R. M., Ganther H. E. Chemical Form of Selenium, Critical Metabolites, and CancerPrevention. Cancer Res. 1991; 51: 595–600
   PubMed Web of Science ®Google Scholar
• Vanhanavikit S., Ip C., Ganther H. E. Metabolites of Sodium Selenite and Methylated Selenium CompoundsAdministered at Cancer Chemoprevention Levels in the Rat. Xenobiotica 1993; 23: 731–745
   PubMed Web of Science ®Google Scholar
• Fisher B., Costantino J. P., Wickerham D. L., et al. Tamoxifen for Prevention of Breast Cancer: Report of the NationalSurgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 1998; 90: 1371–1388
   PubMed Web of Science ®Google Scholar
• Peto R., Doll R., Buckley J. D., Sporn M. B. Can Dietary Beta-Carotene Materially Reduce Human Cancer Rates. Nature 1981; 290: 201–208
   PubMed Web of Science ®Google Scholar
• The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group(ATBC). The Effect of Vitamin E and Beta-Carotene on the Incidence of LungCancer and Other Cancers in Male Smokers. N. Engl. J. Med. 1994; 330: 1029–1035
   PubMed Web of Science ®Google Scholar
• Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L., Valanis B., Williams J. H., Barnhart S., Hammar S. Effects of a Combination of Beta Carotene and Vitamin A on LungCancer and Cardiovascular Disease. N. Engl. J. Med. 1996; 33: 1150–1155
   Google Scholar
• Clark L. C., Dalkin B., Krongrad A., Combs G. F., Jr., Turnbull B. W., Slate E. H., Witherington R., Herlong J. H., Janosko E., Carpenter D., Borosso C., Falk S., Rounder J. Decreased Incidence of Prostate Cancer with Selenium Supplementation:Results of a Double Blind Cancer Prevention Trial. Brit. J. Urol. 1998; 81: 730–734
   PubMedGoogle Scholar
• Clark L. C., Combs G. F., Jr., Turnbull B. W. Unpublished research 2000
   Google Scholar
• Blot W. J., Li J. Y., Taylor P. R., Guo W., Dawsey S., Wang G. Q., Yang C. S., Zheng S. F., Gail M., Li G. Y., Yu Y., Liu B. Q., Tangrea J., Sun Y. H., Liu F., Fraumeni J. F., Jr., Zhang Y. H., Li B. Nutrition Intervention Trials in Linxian, China: Supplementationwith Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-SpecificMortality in the General Population. J. Natl. Cancer Inst. 1993; 85: 1483–1491
   PubMed Web of Science ®Google Scholar
• Li J. Y., Talor P. R., Li B., Blot W. J., Guo W., Dawsey S., Wang G. Q., Yang C. S., Zheng S. F., Gail M., Li G. Y., Liu B. Q., Tangrea J., Sun Y. H., Liu F., Fraumeni F., Jr., Zhang Y. H. Nutrition Intervention Trials in Linxian, China. J. Natl. Cancer Inst. 1993; 85: 1492–1498
   PubMed Web of Science ®Google Scholar
• Huang Q. S., Huang C. Z., Zhang Q. N., Hou C. A Preliminary Report on the Intervention Trials of Primary LiverCancer in High Risk Populations with Nutritional Supplementation of Seleniumin China. Biol. Trace Elem. Res. 1991; 29(3)289–294
   PubMed Web of Science ®Google Scholar
• Colditz G. A. Selenium and Cancer Prevention: Promising Results Indicate FurtherTrials Required. J. Natl. Cancer Inst. 1996; 276: 1984–1985, (editorial)
   Google Scholar
• Ip C., Lisk D. J., Thompson H. J. Selenium-Enriched Garlic Inhibits the Early Stage but Not theLate Stage of Mammary Carcinogenesis. Carcinogenesis 1996; 17: 1979–1982
   PubMed Web of Science ®Google Scholar
• Bonnelli L., et al. Chemopreventionof Metachronous Adenomas of the Large Bowel by Means of Antioxidants: A Double-BlindRandomized Trial. InternationalSelenium Tellurium Development AssociationScottsdale, AZ 1998
   Google Scholar
• Krishnaswamy K., Prasad M. P., Krishna T. P., Annapurma V. V., Reddy G. A. A Case Study of Nutrient Intervention of Oral Precancerous Lesionsin India. Eur. J. Cancer B Oral Oncol. 1995; 31B: 41–48
   PubMed Web of Science ®Google Scholar
• Bird S. M., Uden P. C., Tyson J. F., Block E., Denoyer E. Speciation of Selenoamino Acids and Organoselenium Compoundsin Selenium-Enriched Yeast Using High Performance Liquid Chromatography-InductivelyCoupled Plasma Mass Spectrometry. J. Anal. Atom. Spectrom. 1997; 12: 785–788
   Web of Science ®Google Scholar
• Cai X., Block E., Uden P., Zhang X., Quimby B. D., Sullivan J. J. Allium Chemistry: Identification of Selenoanimo Acids in Ordinaryand Selenium Enriched Garlic, Onion and Broccoli Using Gas Chromatographywith Atomic Emission Detection. J. Agric. Food Chem. 1995; 43: 1754–1757
   Web of Science ®Google Scholar
• Yang G. Q., Zhou R., Yin S., Gu L., Yan B., Liu Y., Liu Y., Li X. Studies of Safe Maximal Daily Dietary Se Intake in a SeleniferousArea in China, 1: Selenium Intake and Tissue Selenium Levels of the Inhabitants. J. Trace Elem. Electrolytes Health Dis. 1989; 3: 77
   PubMed Web of Science ®Google Scholar
• Yang G. Q., Yin S., Zhou R. Studies of Safe Maximal Daily Dietary Se Intake in a SeleniferousArea in China, 2: Relation Between Se Intake and the Manifestations of ClinicalSigns and the Certain Biochemical Alterations in Blood and Urine. J. Trace Elem. Electrolytes Health Dis. 1989; 3: 123
   PubMed Web of Science ®Google Scholar
• Combs G. F., Jr., Combs S. Effects of Selenium Excess. The Role of Selenium in Nutrition, G. F. Combs, Jr., S. Combs. Academic, New York 1986; 463–525
   Google Scholar
• Abernathy C. O., Cantilli R., Du J. T., et al. Essentiality Versus Toxicity: Some Considerations in the Risk Assessment of Essential Trace Elements. Hazard Assessment of Chemical, J. Saxena. Hemisphere, New York 1992; 8
   Google Scholar
• Whanger P., Vendeland S., Park Y. C., et al. Metabolism of Subtoxic Levels of Selenium in Animals and Humans. Ann. Clin. Lab. Sci. 1996; 26: 99–113
   PubMed Web of Science ®Google Scholar
• Yang G. Q., Xia Y. Studies on Human Dietary Requirements and Safe Range of DietaryIntakes of Selenium in China and Their Application in the Prevention of RelatedEndemic Diseases. Biomed. Environ. Sci. 1995; 8: 187–201
   PubMedGoogle Scholar
• Combs G. F., Jr. Essentially and Toxicity of Selenium: A Critique of the Recommended Dietary Allowance and the Reference Dose. Risk Assessment of Essential Elements, W. Mertz, S. S. Olins. ILISPress, Washington, DC 1994; 167–183
   Google Scholar
• Myers M. G., Cairns J. A., Singer J. The Consent Form as a Possible Cause of Side Effects. Clin. Pharmacol. Ther. 1987; 42: 250–253
   PubMed Web of Science ®Google Scholar
• Prentice R. L. Experimental Methods in Cancer Prevention Research. Cancer Prevention and Control, P. Greenwald, B. Kramer, D. Weed. Marcel Dekker, New York 1995; 8: 213–224
   Google Scholar
• Miller N. H. Compliance with Treatment Regimens in Chronic Asymptomatic Diseases. Am. J. Med. 1997; 102: 43–49
   PubMedGoogle Scholar
• Patterson B. H., Levander O. A., Helzlsour K., Mc-Adam P. A., Lewis S. A., Taylor P. R., Veillon C., Zech L. A. Human Selenite Metabolism: A Kinetic Model. Am. J. Physiol 1987; 257: R556–R567
   Web of Science ®Google Scholar
• Slesinski M., Subar A., Kahle L. Trends in Use of Vitamin and Mineral Supplements in the US:The 1987 and 1992 National Health Interview Surveys. J. Am. Diet. Assoc. 1995; 95: 921–923
   PubMed Web of Science ®Google Scholar
• Combs G. F., Jr., Scott M. L. Antioxidant Effects on Selenium and Vitamin E Function in theChick. J. Nutr. 1994; 106: 1297
   Google Scholar
• Diplock A. T. The Role of Vitamin E selenium in the Prevention of Oxygen-Induced Tissue Damage. Selenium in Biology and Medicine, J. Spallholz, J. L. Martin, H. E. Ganther. AVI, Westport, CT 1981; 303
   Google Scholar
• Yu S. Y., Zhu Y. J., Li W. G. Protective Role of Selenium Level in Toenails and the Risk ofAdvanced Prostate Cancer in Qidong. Biol. Trace Elem. Res. 1997; 56: 117–124
   PubMed Web of Science ®Google Scholar
• Lee J. S., Lippman S. M., Hong W. K., Ro J. Y., Kim S. Y., Lotan R., Hittelman W. N. Determination of Biomarkers for Intermediate End Points in ChemopreventionTrials. Cancer Res. 1992; 52(suppl)2707–2710
   Google Scholar
• Doran T. C. A Method for the Analysis of Dimethlselenide in Human Blood. Thesis University of Wisconsin, 1988
   Google Scholar
• Ip C., Thompson H. J., Ganther H. E. Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkersin Normal and Premalignant Cells of the Rat Mammary Gland. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 49–54
   PubMed Web of Science ®Google Scholar
• Palcic B. Nuclear Texture: Can It Be Used as a Surrogate Endpoint Biomarker. J.Cell Biochem. Suppl. 1994; 19: 40–46
   PubMedGoogle Scholar
• Greenberg S. D., Spjut H. J., Estrada R. G., Hunter N. R., Grenia C. Morphometric Markers for the Evaluation of Preneoplastic Lesionsin the Lung. Diagnostic Evaluation by High-Resolution Image Analysis of AtypicalCell in Sputum Specimens. Anal. Quant. Cytol. Histol. 1987; 9: 49–54
   PubMed Web of Science ®Google Scholar
• Tockman M. S. Clinical Detection of Lung Cancer Progression Markers. J.Cell Biochem. Suppl. 1996; 25: 177–184
   PubMedGoogle Scholar
• Crawford E. D. The Utility of Prostate-Specific Antigen as a Surrogate Markerfor Identification of High-Risk Cohorts and Assessing Response in ChemopreventionTrials. Eur. Urol. 1999; 35: 511–514
   PubMed Web of Science ®Google Scholar
• Moriwaki H., Yasuda I., Shiratori Y., Uematsu T., Okuno M., Muto Y. Deletion of Serum Lectic-Reactive Alpha-Fetoprotein by AcyclicRetinoid: A Potent Biomarker in the Chemoprevention of Second Primary Hepatoma. Clin. Cancer Res. 1997; 3: 727–731
   PubMed Web of Science ®Google Scholar
• Hanahan D., Folkman J. Patterns and Emerging Mechanisms of the Angiogenic Switch DuringTumorigenesis. Cell 1996; 86: 353–364
   PubMed Web of Science ®Google Scholar
• Bouck N., Stellmach V., Hsu S. C. How Tumors Become Angiogenic. Adv. Cancer Res. 1996; 69: 135–174
   PubMed Web of Science ®Google Scholar